Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

Similar articles for PubMed (Select 21440036)

1.

A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.

Forrest BD, Steele AD, Hiemstra L, Rappaport R, Ambrose CS, Gruber WC.

Vaccine. 2011 May 9;29(20):3633-9. doi: 10.1016/j.vaccine.2011.03.029. Epub 2011 Apr 5.

PMID:
21440036
2.

Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine.

Cox A, Baker SF, Nogales A, Martínez-Sobrido L, Dewhurst S.

J Virol. 2015 Mar;89(6):3421-6. doi: 10.1128/JVI.02636-14. Epub 2014 Dec 31.

PMID:
25552727
3.

Safety and efficacy of inactivated influenza vaccines in children.

Collignon P, Doshi P, Del Mar C, Jefferson T.

Clin Infect Dis. 2015 Feb 1;60(3):489. doi: 10.1093/cid/ciu835. Epub 2014 Oct 23. No abstract available.

PMID:
25344541
4.

Influenza vaccine for 2014-2015.

[No authors listed]

Med Lett Drugs Ther. 2014 Oct 13;56(1453):97-9. No abstract available.

PMID:
25296257
5.

Intradermal trivalent influenza vaccination in nursing home older adults.

Wiwanitkit V.

J Am Med Dir Assoc. 2014 Oct;15(10):773. doi: 10.1016/j.jamda.2014.07.004. No abstract available.

PMID:
25260500
6.

Response to comments on "immunogenicity and safety of intradermal trivalent influenza vaccination in nursing home older adults: a randomized controlled trial".

Chan TC, Hung IF, Chan KH, Li CP, Li PT, Luk JK, Chu LW, Chan FH.

J Am Med Dir Assoc. 2014 Oct;15(10):773-4. doi: 10.1016/j.jamda.2014.07.014. No abstract available.

PMID:
25260499
7.

[Live attenuated and inactivated influenza vaccines: data from direct comparative studies].

Kashirina OS, Vasil'ev IuM.

Zh Mikrobiol Epidemiol Immunobiol. 2014 Jan-Feb;(1):103-19. Review. Russian.

PMID:
24738303
8.

Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.

Cao RG, Suarez NM, Obermoser G, Lopez SM, Flano E, Mertz SE, Albrecht RA, García-Sastre A, Mejias A, Xu H, Qin H, Blankenship D, Palucka K, Pascual V, Ramilo O.

J Infect Dis. 2014 Jul 15;210(2):224-33. doi: 10.1093/infdis/jiu079. Epub 2014 Feb 4.

PMID:
24495909
9.

Influenza vaccines: unmet needs and recent developments.

Noh JY, Kim WJ.

Infect Chemother. 2013 Dec;45(4):375-86. doi: 10.3947/ic.2013.45.4.375. Epub 2013 Dec 27. Review.

10.

An update on influenza vaccines for the 2013-14 flu season.

Jansen T.

S D Med. 2013 Aug;66(8):323-5. Review. No abstract available.

PMID:
24175498
11.

Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany.

Falkenhorst G, Harder T, Remschmidt C, Terhardt M, Zepp F, Ledig T, Wicker S, Keller-Stanislawski B, Mertens T.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Nov;56(11):1557-64. doi: 10.1007/s00103-013-1844-9. Erratum in: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Apr;57(4):473-4.

PMID:
24170085
12.

Update on influenza vaccination of egg allergic patients.

Kelso JM, Greenhawt MJ, Li JT; Joint Task Force on Practice Parameters (JTFPP).

Ann Allergy Asthma Immunol. 2013 Oct;111(4):301-2. doi: 10.1016/j.anai.2013.07.030. Epub 2013 Aug 20. No abstract available.

PMID:
24054370
13.

The quadrivalent approach to influenza vaccination.

Dolin R.

J Infect Dis. 2013 Aug 15;208(4):539-40. doi: 10.1093/infdis/jit264. Epub 2013 Jul 11. No abstract available.

14.

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.

Langley JM, Carmona Martinez A, Chatterjee A, Halperin SA, McNeil S, Reisinger KS, Aggarwal N, Huang LM, Peng CT, Garcia-Sicilia J, Salamanca de la Cueva I, Cabañas F, Treviño-Garza C, Rodríguez-Weber MA, de la O M, Chandrasekaran V, Dewé W, Liu A, Innis BL, Jain VK.

J Infect Dis. 2013 Aug 15;208(4):544-53. doi: 10.1093/infdis/jit263. Epub 2013 Jul 11. Erratum in: J Infect Dis. 2014 May 1;209(9):1494.

15.

Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison.

Scheifele DW, McNeil SA, Ward BJ, Dionne M, Cooper C, Coleman B, Loeb M, Rubinstein E, McElhaney J, Hatchette T, Li Y, Montomoli E, Schneeberg A, Bettinger JA, Halperin SA; PHAC /CIHR Influenza Research Network.

Hum Vaccin Immunother. 2013 Nov;9(11):2460-73. Epub 2013 Jul 9.

16.

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults.

Beran J, Peeters M, Dewé W, Raupachová J, Hobzová L, Devaster JM.

BMC Infect Dis. 2013 May 20;13:224. doi: 10.1186/1471-2334-13-224.

17.

[Influenza vaccination. Waiting for the holy grail].

[No authors listed]

MMW Fortschr Med. 2013 Mar 7;155(4):21. German. No abstract available.

PMID:
23614186
18.

Vaccination induced neutropenia.

Griffin M, Makris M.

Int J Lab Hematol. 2013 Oct;35(5):e33. doi: 10.1111/ijlh.12063. Epub 2013 Mar 22. No abstract available.

PMID:
23521785
19.

[Hopeful vaccines: influenza and tuberculosis in reverse].

Nau JY.

Rev Med Suisse. 2013 Feb 13;9(373):386-7. French. No abstract available.

PMID:
23477075
20.

Complexities in assessing the effectiveness of inactivated influenza vaccines.

Kelly H, Steffens I.

Euro Surveill. 2013 Feb 14;18(7):1. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk